150 related articles for article (PubMed ID: 6098816)
1. Cholera toxin treatment stimulates tumorigenicity of Rous sarcoma virus-transformed cells.
Gottesman MM; Roth C; Vlahakis G; Pastan I
Mol Cell Biol; 1984 Dec; 4(12):2639-42. PubMed ID: 6098816
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP treatment of Rous sarcoma virus-transformed Chinese hamster ovary cells increases phosphorylation of pp60src and increases pp60src kinase activity.
Roth CW; Richert ND; Pastan I; Gottesman MM
J Biol Chem; 1983 Sep; 258(17):10768-73. PubMed ID: 6309814
[TBL] [Abstract][Full Text] [Related]
3. Rous sarcoma virus transformed cells are resistant to cyclic AMP.
Roth CW; Singh T; Pastan I; Gottesman MM
J Cell Physiol; 1982 Apr; 111(1):42-8. PubMed ID: 6282904
[TBL] [Abstract][Full Text] [Related]
4. Reduced synthesis of pp60src and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells.
Lin SL; Garber EA; Wang E; Caliguiri LA; Schellekens H; Goldberg AR; Tamm I
Mol Cell Biol; 1983 Sep; 3(9):1656-64. PubMed ID: 6314124
[TBL] [Abstract][Full Text] [Related]
5. Correlation between phosphorylation of a 34,000-molecular-weight protein, pp60src-associated kinase activity, and tumorigenicity in transformed and revertant vole cells.
Nawrocki JF; Lau AF; Faras AJ
Mol Cell Biol; 1984 Jan; 4(1):212-5. PubMed ID: 6321952
[TBL] [Abstract][Full Text] [Related]
6. Tyrosyl and cyclic AMP-dependent protein kinase activities in BHK cells that express viral pp60src.
Clinton GM; Roskoski R
Mol Cell Biol; 1984 May; 4(5):973-7. PubMed ID: 6328280
[TBL] [Abstract][Full Text] [Related]
7. Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation.
Cross FR; Hanafusa H
Cell; 1983 Sep; 34(2):597-607. PubMed ID: 6311433
[TBL] [Abstract][Full Text] [Related]
8. Regulation of adenosine 3':5'-monophosphate content of rous sarcoma virus-transformed human astrocytoma cells. Effects of cholera toxin on the responsiveness to catecholamines and prostaglandins.
Johnson GL; Harden TK; Perkins JP
J Biol Chem; 1978 Mar; 253(5):1465-71. PubMed ID: 203593
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of pp60src and the cycloheximide insensitive activation of the pp60src-associated kinase activity of transformation-defective temperature-sensitive mutants of Rous sarcoma virus.
Ziemiecki A; Friis RR
Virology; 1980 Oct; 106(2):391-4. PubMed ID: 6254260
[No Abstract] [Full Text] [Related]
10. Changes in amino-terminal sequences of pp60src lead to decreased membrane association and decreased in vivo tumorigenicity.
Krueger JG; Garber EA; Goldberg AR; Hanafusa H
Cell; 1982 Apr; 28(4):889-96. PubMed ID: 6284379
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between pp60src kinase activity and transformation parameters in cells infected with temperature-conditional mutants of Rous sarcoma virus.
Weber MJ; Rubsamen H; Friis RR
J Gen Virol; 1981 Feb; 52(Pt 2):395-9. PubMed ID: 6270240
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the solubilized insulin receptor by the gene product of the Rous sarcoma virus, pp60src.
White MF; Werth DK; Pastan I; Kahn CR
J Cell Biochem; 1984; 26(3):169-79. PubMed ID: 6098589
[TBL] [Abstract][Full Text] [Related]
13. Neoplastic transformation of normal and carcinogen-induced preneoplastic Syrian hamster embryo cells by the v-src oncogene.
Gilmer TM; Annab LA; Oshimura M; Barrett JC
Mol Cell Biol; 1985 Jul; 5(7):1707-13. PubMed ID: 2991747
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenicity of partial transformation mutants of Rous sarcoma virus.
Kahn P; Nakamura K; Shin S; Smith RE; Weber MJ
J Virol; 1982 May; 42(2):602-11. PubMed ID: 6177871
[TBL] [Abstract][Full Text] [Related]
15. Increase in the phosphotransferase specific activity of purified Rous sarcoma virus pp60v-src protein after incubation with ATP plus Mg2+.
Purchio AF; Wells SK; Collett MS
Mol Cell Biol; 1983 Sep; 3(9):1589-97. PubMed ID: 6314123
[TBL] [Abstract][Full Text] [Related]
16. Loss of tumorigenicity correlates with a reduction in pp60src kinase activity in a revertant subclone of avian sarcoma virus-infected field vole cells.
Lau AF; Krzyzek RA; Faras AJ
Cell; 1981 Mar; 23(3):815-23. PubMed ID: 6261958
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Rous sarcoma virus src gene in avian macrophages fails to elicit transformed cell phenotype.
Lipsich L; Brugge JS; Boettiger D
Mol Cell Biol; 1984 Jul; 4(7):1420-4. PubMed ID: 6095071
[TBL] [Abstract][Full Text] [Related]
18. Morphological revertants of an avian sarcoma virus-transformed mammalian cell line exhibit tumorigenicity and contain pp60src.
Lau AF; Krzyzek RA; Brugge JS; Erikson RL; Schollmeyer J; Faras AJ
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):3904-8. PubMed ID: 226988
[TBL] [Abstract][Full Text] [Related]
19. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine.
Hunter T; Sefton BM
Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1311-5. PubMed ID: 6246487
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of a 50K cellular polypeptide associated with the Rous sarcoma virus transforming protein pp60src.
Gilmore TD; Radke K; Martin GS
Mol Cell Biol; 1982 Feb; 2(2):199-206. PubMed ID: 6287229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
